Contrasting Effects of the γ-Aminobutyric Acid Type A Receptor β3 Subunit N265M Mutation on Loss of Righting Reflexes Induced by Etomidate and the Novel Anesthetic Barbiturate R–mTFD-MPAB: Erratum
First, the x-axis of figure 2b is incorrectly labeled “etomidate dose (mg/kg)” when it should be “R-mTFD-MPAB dose (mg/kg).”
Secondly, the second sentence of the fourth paragraph in the Results section reads: “The 2.5, 5, and 10 mg/kg doses yielded median RORR times of [137.75], 348 , and 926  seconds, respectively.” The number “113.5” is omitted. The sentence should read “The 2.5, 5, and 10 mg/kg doses yielded median RORR times of 113.5 [137.75], 348 , and 926  seconds, respectively.”
The third paragraph of the Methods section states that etomidate was dissolved in sterile saline. This is incorrect. The sentence should read “Etomidate (Tocris Bioscience, Bristol, UK) was dissolved in dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO) to 5mg/ml stock solution.”
The authors and publishers regret these errors.